DrugDev to Sponsor CISCRP’s AWARE for All International Event in London to Provide Clinical Research Education

Share Article

Innovative provider of technology-driven solutions for clinical trials promotes patient-focused research.

The Center for Information and Study on Clinical Research Participation (CISCRP) is thrilled to announce its first international AWARE for All event in London, UK on 9 June, 2015. This complimentary program is designed to improve understanding about clinical research participation and promote dialogue by connecting patients, researchers, and members of the general public in the local community.

The AWARE for All London event is sponsored by DrugDev, a leading global technology company that provides unified solutions to help sponsors, CROs and sites do more trials together. Additional sponsors include Merck Serono and the Association of Clinical Research Professionals (ACRP).

The event which takes place at London’s Camden Centre on Euston Road (across from King’s Cross and St. Pancras Station) on Tuesday, 9 June 2015 from 16:00 to 20:00 and will be co-hosted by the European Patients’ Academy on Therapeutic Innovation (EUPATI), European Patients Forum, and other local healthcare partners. The program will feature free health screenings, informational exhibits, meaningful presentations from both prominent medical professionals about various health conditions, and community patients involved in clinical research, as well as refreshments and prizes.

This no-cost event is open to the public; however, advanced registration is strongly encouraged through http://www.awareforall.org or by emailing awareforall(at)ciscrp(dot)org.

Explained Ken Getz, Founder and Chairman of the Board at CISCRP, “Most participants are uncertain about the research process and of what to expect before they take part. Ultimately, CISCRP hopes to empower patients and the public to make more informed decisions about clinical research. This first international event signals CISCRP’s expanding involvement in providing live education and outreach to patients and the public throughout the world.”

“The goal of the AWARE for All event is to help our diverse communities understand all of their treatment options so that they can make the best decision for themselves and their families,” said Claire Sears, PhD, Director of Investigator Engagement at DrugDev and member of the AWARE for All Planning Committee. "This program is a wonderful opportunity to learn more about clinical research and to hear first-hand the personal insights of those who have volunteered to participate in clinical trials. We also have some great doctors and researchers speaking.”

Added DrugDev President and CEO Ibraheem (Ibs) Mahmood, “Participation in clinical trials is a personal gift given by patients as well as a viable treatment option, so the patients’ safety, comfort and convenience must be at the center of clinical research. We’re delighted and honored to be part of the AWARE for All event which focuses on the importance of patients in the clinical trial process and helps to educate them about options.”

The Center for Information and Study (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to support CISCRP’s educational initiatives.

About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
+1 617.688.3253
Email >

Maya Wise
+1 617-725-2750
Email >
Follow >
Visit website